Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Treatment of Shiga Toxin-Producing Infections

Primary Treatment Approach

  • Aggressive fluid management is the only proven effective treatment for STEC infections, with early parenteral volume expansion crucial to prevent HUS development 1
  • For mild to moderate dehydration: Use reduced osmolarity oral rehydration solution (ORS) as first-line therapy 1, 2
  • For severe dehydration, shock, altered mental status, or ORS failure: Administer isotonic intravenous fluids (lactated Ringer's or normal saline) 1, 2

Critical Monitoring Requirements

  • Close surveillance for HUS development is mandatory, particularly in children under 5 years who face the highest risk 1
  • Monitor specifically for the HUS triad: thrombocytopenia, hemolytic anemia, and renal failure 1
  • Continue monitoring even after diarrhea resolves, as HUS can develop days after initial symptoms 3

Diagnostic Considerations

  • Prompt and accurate diagnosis enables appropriate supportive care and prevents inappropriate antibiotic use 1
  • All stools from patients with acute community-acquired diarrhea should be simultaneously cultured for E. coli O157:H7 and tested with Shiga toxin assays 3, 4
  • Testing should occur regardless of patient age, season, or presence of blood in stool 3
  • Specimens should be collected as soon as possible after diarrhea onset, while acutely ill, and before any antibiotic administration 5, 6

Public Health Implications

  • All confirmed STEC cases must be reported to public health authorities for outbreak detection and control 3, 7
  • Food-service workers and childcare attendees may require negative follow-up cultures before returning to work/school per state regulations 5, 6